Answers are grounded in this paper and cite their sources.
Valproic acid exhibits three unique pharmacological and pharmacokinetic characteristics: (a) a nonreversible pharmacologic effect, (b) a nonlinear level-dose relationship, and (c) a high and variable degree of plasma protein binding. These properties and their clinical implications are discussed and a case is made for monitoring free vs total plasma levels in specific circumstances.
No takes yet. Share an insight, caveat, or question.
René H. Levy (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: